Stocks of makers of COVID vaccines, Moderna MRNA, Pfizer PFE, Novavax NVAX and BioNTech BNTX rose on Friday on reports of a new bat coronavirus being discovered in China. What is the New Coronavirus?

B. Riley decreased their FY2024 earnings estimates for Novavax in a report issued on Thursday, February 20th. B. Riley ...

Researchers from the Wuhan Institute of Virology in China have discovered a new strain of the coronavirus in bats, which ...

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

The new discovery raises the possibility that it could some day spread to humans. Read more at straitstimes.com.

Moderna Inc. rose by as much as 6.6%, while Novavax Inc. climbed 7.8%. American depositary receipts of BioNTech SE, the partner of Pfizer in the development of the Covid vaccine, surged by 5.1%, and ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%.

The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, ...

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...